Table 2.
Individual values for tumor diffusivity and morphological tumor volumes at baseline and follow-up
| Number | Groupa | ADCBaseline (mm2x10−3/s) | ADCFollow-up (mm2x10−3/s) | ∆ADC (mm2x10−3/s) | VolumeBaseline (mm3) | VolumeFollow-up (mm3) | ∆Volume (mm3) |
|---|---|---|---|---|---|---|---|
| 1 | T | 0.84 | 0.84 | 0.00 | 163.0 | 166.3 | 3.3 |
| 2 | T | 0.88 | 1.16 | 0.28 | 25.7 | 33.5 | 7.8 |
| 3 | T | 0.74 | 0.72 | −0.02 | 19.1 | 99.5 | 80.4 |
| 4 | T | 0.77 | 0.86 | 0.09 | 188.8 | 255.5 | 66.7 |
| 5 | T | 0.87 | 0.82 | −0.05 | 88.5 | 281.1 | 192.6 |
| 6 | T | 0.62 | 0.84 | 0.22 | 154.9 | 107.7 | −47.2 |
| 7 | T | 0.79 | 1.07 | 0.28 | 67.2 | 48.3 | −18.9 |
| 8 | T | 0.71 | 0.87 | 0.16 | 38.7 | 50.8 | 12.1 |
| 9 | T | 0.66 | 0.83 | 0.17 | 232.5 | 264.1 | 31.6 |
| 10 | T | 0.73 | 0.81 | 0.08 | 62.0 | 123.0 | 61.0 |
| 11 | T | 0.76 | 1.07 | 0.31 | 48.9 | 31.9 | −17.0 |
| 12 | T | 0.97 | 0.85 | −0.12 | 45.6 | 107.9 | 62.3 |
| Mean ± SDb | T | 0.78 ± 0.10 | 0.90 ± 0.13 | 0.12 ± 0.14 | 94.6 ± 71.4 | 130.8 ± 91.3 | 36.2 ± 63.2 |
| 13 | C | 0.85 | 0.77 | −0.08 | 119.0 | 356.0 | 237.0 |
| 14 | C | 0.70 | 0.63 | −0.07 | 320.6 | 777.6 | 457.0 |
| 15 | C | 0.86 | 0.69 | −0.17 | 103.1 | 379.7 | 276.6 |
| 16 | C | 0.96 | 0.76 | −0.20 | 81.5 | 212.9 | 131.4 |
| 17 | C | 0.78 | 0.63 | −0.15 | 138.0 | 371.4 | 233.4 |
| 18 | C | 0.73 | 0.61 | −0.12 | 109.0 | 292.9 | 183.9 |
| 19 | C | 0.87 | 0.71 | −0.16 | 72.7 | 301.7 | 229.0 |
| 20 | C | 0.61 | 0.61 | 0.00 | 232.7 | 541.0 | 308.3 |
| 21 | C | 0.79 | 0.69 | −0.10 | 31.8 | 203.5 | 171.7 |
| Mean ± SDb | C | 0.79 ± 0.10 | 0.68 ± 0.06 | −0.12 ± 0.06 | 134.3 ± 89.0 | 381.9 ± 179.4 | 247.6 ± 95.1 |
aT = therapy group; C = control group
bSD = standard deviation